DD

Dhruv Desai

Active Director Managing Director DIN 08563139
DIN 08563139 First appointment Sep 2019 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 3 historical roles
Total affiliations 7 Since Sep 2019
Shareholding value •••• Premium profile

About Dhruv Desai

Data last updated:

Dhruv Desai has 7 years in corporate governance. Holds Managing Director and Director roles. Currently with 4 companies, including Infinion Biopharma Limited and Amphina Therapeutics Private Limited. Formerly with 3 companies, such as Axgen Chemicals Private Limited and Celliimune Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹1.17 Cr; the largest is Infinion Biopharma Limited at ₹91.8 Lakh (FY 2025).

DIN 08563139
Primary Designation Managing Director
First Appointment 20 Sep 2019
Oldest Company Age 8 yrs
Largest company Infinion Biopharma Limited · ₹91.8 Lakh (FY 2025)
Combined revenue ₹1.17 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Infinion Biopharma Limited U51909GJ2018PLC100571
Managing Director07 Sep 20252018₹91.8 Lakh (FY 2025)Active
Amphina Therapeutics Private Limited U85100GJ2020PTC112901
Director05 Aug 20242020₹25.4 Lakh (FY 2025)Active
Designated Partner21 Aug 20262026–Active
Designated Partner25 Feb 20262026–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Axgen Chemicals Private Limited U46691GJ2024PTC152745
Director22 Jun 20242024–Active
Director26 May 20222022–Active
Axegis (India) Private Limited U36994GJ2019PTC108384
Director20 Sep 20192019₹2.84 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Infinion Biopharma Limited
Amphina Therapeutics Private Limited
Posha Organics Llp
Ishwara Enterprise Llp
Premium access

Shareholding and investment profile for Dhruv Desai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhruv Desai

Dhruv Desai has 7 years in corporate governance. Holds Managing Director and Director roles. Currently with 4 companies, including Infinion Biopharma Limited and Amphina Therapeutics Private Limited. Formerly with 3 companies, such as Axgen Chemicals Private Limited and Celliimune Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹1.17 Cr; the largest is Infinion Biopharma Limited at ₹91.8 Lakh (FY 2025).

Dhruv Desai is associated with 4 companies as Managing Director and Director, including Infinion Biopharma Limited (₹91.8 Lakh), Amphina Therapeutics Private Limited (₹25.4 Lakh), Ishwara Enterprise Llp.

Dhruv Desai has expertise in General Business.

Dhruv Desai has 7 years in corporate governance.

By reported revenue, the largest current company of Dhruv Desai is Infinion Biopharma Limited, with revenue of ₹91.8 Lakh (FY 2025).

The 2 current companies of Dhruv Desai that report revenue have a combined latest revenue of ₹1.17 Cr.

Dhruv Desai currently holds positions at 4 companies: Infinion Biopharma Limited (₹91.8 Lakh), Amphina Therapeutics Private Limited (₹25.4 Lakh), Ishwara Enterprise Llp, Posha Organics Llp.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available